E. coli enhances the malignancy of ICC by upregulating the expression of splicing factor eIF4A3, promoting the assembly of SGs, and leading to sustained activation of the NF‐κB pathway. Here, NFKB1 is linked to intrahepatic cholangiocarcinoma.